| CTRI Number |
CTRI/2020/01/022971 [Registered on: 27/01/2020] Trial Registered Prospectively |
| Last Modified On: |
16/01/2020 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Surgical/Anesthesia |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Comparison of two medications Dexmedetomidine and Magnesium Sulphate for control of blood pressure and heart rate during surgery and their effects on pain relief after surgery |
|
Scientific Title of Study
|
Comparison between intravenous Dexmedetomidine and Magnesium Sulphate on intraoperative hemodynamics and postoperative pain in lumbar spine surgeries: A randomised controlled trial |
| Trial Acronym |
MADE |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Albin Aloysius Chettanil |
| Designation |
Postgraduate Student |
| Affiliation |
St Johns Medical College |
| Address |
Albin Aloysius Chettanil
room no. 5,6
Operation theatre complex
Department of Anesthesia and Critical Care
St Johns Medical College Hospital
Sarjapur Road
Bangalore 560034
Bangalore KARNATAKA 560034 India |
| Phone |
8951190342 |
| Fax |
|
| Email |
albinchettanil@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr M Manjula Devi |
| Designation |
Associate Professor |
| Affiliation |
St Johns Medical College |
| Address |
Dr M Manjula Devi
Room no. 5,6
Operation theatre complex
Department of Anesthesia and Critical Care
St Johns Medical College Hospital
Sarjapur Road
Bangalore 560034
Bangalore KARNATAKA 560034 India |
| Phone |
9449059395 |
| Fax |
|
| Email |
drmanjula95@yahoo.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Albin Aloysius Chettanil |
| Designation |
Postgraduate student |
| Affiliation |
St. John’s Medical College |
| Address |
Albin Aloysius Chettanil
Room no. 5,6
Operation theatre complex
Department of Anesthesia and Critical Care
St Johns Medical College Hospital
Sarjapur Road
Bangalore 560034
Bangalore KARNATAKA 560034 India |
| Phone |
8951190342 |
| Fax |
|
| Email |
albinchettanil@gmail.com |
|
|
Source of Monetary or Material Support
|
| St Johns Medical College Hospital
Sarjapur Main Road Bangalore Karnataka 560034 |
|
|
Primary Sponsor
|
| Name |
St Johns Medical College And Hospital Bangalore |
| Address |
St Johns Medical College Sarjapur Main Road Bangalore Karnataka 560034 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Albin Aloysius Chettanil |
St Johns Medical College Hospital |
Operation Theatre Complex, room no. 4,5.
2nd floor, Anaesthesia department.
Bangalore KARNATAKA |
08951190342
albinchettanil@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional ethics committee St. John’s Medical College and Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: M259||Joint disorder, unspecified, (2) ICD-10 Condition: M512||Other thoracic, thoracolumbar andlumbosacral intervertebral disc displacement, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Group D: Intravenous Dexmedetomidine |
Bolus dose of Dexmedetomidine 1mcg/kg in 100ml Normal Saline over 15 min followed by maintenance of 0.3mcg/kg/hr until end of surgery.
|
| Intervention |
Group M: Intravenous Magnesium |
Bolus dose of Magnesium Sulpfate 30mg/kg in 100ml Normal Saline over 15 min followed by maintenance of 8mg/kg/hr until end of surgery. |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
59.00 Year(s) |
| Gender |
Both |
| Details |
Adults aged 18-59 years,
undergoing elective lumbar spine surgeries
Either sex
American physical status (ASA) I and II |
|
| ExclusionCriteria |
| Details |
Known history of hypersensitivity to drugs used
Pregnant or lactating woman
Previous spine surgeries
Preexisting neuromuscular diseases or myopathy
Coagulation disorders
Patient on Calcium channel blockers and Beta blockers |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
Intraoperative hemodynamics Systolic blood pressure(SBP), Diastolic blood pressure (DBP) , Mean arterial blood pressure (MAP) and heart rate (HR)
|
Every 5min for first half hour and then every 15min thereafter until end of surgery.
|
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| postoperative pain by measuring numeric rating scale |
Parameters are seen in recovery room (0 min, 30min, 1hr, 2hrs) and in ward at 4hrs, 6hrs, 8hrs, 10hrs, 12hrs. |
|
|
Target Sample Size
|
Total Sample Size="50" Sample Size from India="50"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
30/01/2020 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="2" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
NIL |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
|
|
Brief Summary
|
This study is a randomised, double blind, parallel Group, single centre trial comparing the efficacy between intravenous Dexmedetomidine given as Bolus dose of Magnesium Sulpfate 30mg/kg in 100ml Normal Saline over 15 min followed by maintenance of 8mg/kg/hr until end of surgery and intravenous Magnesium Sulphate given as Bolus dose of Dexmedetomidine 1mcg/kg in 100ml Normal Saline over 15 min followed by maintenance of 0.3mcg/kg/hr until end of surgery. The duration of the trial will be a period of two years. The primary outcome measured are intraoperative hemodynamics Systolic blood pressure(SBP), Diastolic blood pressure (DBP) , Mean arterial blood pressure (MAP) and heart rate (HR). The secondary outcome is postoperative pain scores measured with numerical rating scale.
|